1. Home
  2. SN vs VTRS Comparison

SN vs VTRS Comparison

Compare SN & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharkNinja Inc.

SN

SharkNinja Inc.

HOLD

Current Price

$140.66

Market Cap

17.3B

Sector

N/A

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$15.32

Market Cap

18.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SN
VTRS
Founded
1993
1961
Country
United States
United States
Employees
N/A
30000
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3B
18.3B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
SN
VTRS
Price
$140.66
$15.32
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
$133.13
$13.50
AVG Volume (30 Days)
1.7M
8.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
3.21%
EPS Growth
58.84
N/A
EPS
0.85
0.15
Revenue
$6,399,188,000.00
$14,299,900,000.00
Revenue This Year
$15.22
$4.41
Revenue Next Year
$10.74
$1.96
P/E Ratio
$164.85
$101.83
Revenue Growth
15.75
N/A
52 Week Low
$83.12
$8.63
52 Week High
$141.81
$17.53

Technical Indicators

Market Signals
Indicator
SN
VTRS
Relative Strength Index (RSI) 70.99 41.18
Support Level $112.91 $12.90
Resistance Level N/A $16.51
Average True Range (ATR) 5.63 0.45
MACD 1.50 -0.09
Stochastic Oscillator 96.52 25.45

Price Performance

Historical Comparison
SN
VTRS

About SN SharkNinja Inc.

SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment, and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The Company has identified two operating segments, Domestic and International. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: